•
Mar 31, 2024

Omega Healthcare Q1 2024 Earnings Report

Omega Healthcare's financial performance exceeded expectations due to higher interest income and early cash payments related to a turnaround asset, while operating fundamentals showed improvement.

Key Takeaways

Omega Healthcare Investors reported a net income of $69.3 million, or $0.27 per common share, for Q1 2024, compared to $36.8 million, or $0.15 per common share, for Q1 2023. The company completed $75 million in new investments and repaid $42 million in HUD mortgage loans. Revenues for the quarter totaled $243.3 million, an increase of $25.1 million over the same period in 2023.

Net income for the quarter was $69 million, or $0.27 per common share.

Nareit FFO for the quarter was $153 million, or $0.60 per common share.

Adjusted FFO for the quarter was $176 million, or $0.68 per common share.

Completed $75 million in Q1 new investments.

Total Revenue
$243M
Previous year: $218M
+11.5%
EPS
$0.68
Previous year: $0.66
+3.0%
Gross Profit
$168M
Previous year: $214M
-21.6%
Cash and Equivalents
$362M
Previous year: $245M
+47.6%
Total Assets
$9.01B
Previous year: $9.29B
-3.0%

Omega Healthcare

Omega Healthcare

Omega Healthcare Revenue by Segment

Forward Guidance

The Company affirmed that it expects its 2024 Adjusted FFO to be between $2.70 and $2.80 per diluted share.